High-grade NENs are aggressive and early diagnosis is vital to receiving timely treatment.
✅We support clinicians to better understand high-grade NENs with #NETInfo factsheets on 26 types of NENs and related syndromes – available in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
📢March is the European Colorectal Cancer Awareness Month.
👉Let’s put the spotlight on neuroendocrine cancer of the colon.
✅We empower HCPs with #NETInfo factsheet with а comprehensive snapshot of NEN of the colon in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs #ECCAM2026
There is a risk of hypercalcemia and neutropenic sepsis with high-grade NENs. Less than 10% of high-grade NECs will have symptoms of a NEN-associated syndrome e.g. carcinoid syndrome.
✅Download a #NETInfo on high-grade NENs in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Secondary NEN may be present at the time that the primary NEN is discovered – indeed this is quite common and true for more than half of those diagnosed.
✅We need more HCPs to be aware of NENs – download a #NETInfo in your language: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
There is no cure for secondary neuroendocrine cancer. No cure is NOT the same as ‘terminal’, and many people with secondary NENs are living long and well.
📢Let’s help more HCPs to be aware of NENs.
✅Download a #NETInfo in your language: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Secondary neuroendocrine cancer is a term used to describe neuroendocrine cancer cells that have spread, from the place where they started (primary site), to another part of the body (secondary site).
✅Download a #NETInfo in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
January is #AdrenalCancerAwarenessMonth.
📌Let’s talk about #Pheochromocytoma and #AdrenocortiCalcarcinoma (ACC).
✅We help clinicians to get informed at a glance with #NETInfo factsheets in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
NETs can be classified by site into primary and secondary.
👉Primary refers to where the tumor starts and secondary refers to where the cancer has spread to.
✅We support clinicians to be able to suspect NETs with #NETInfo in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
In January we mark #CervicalCancerAwarenessMonth.
👉Neuroendocrine cancer of the cervix presents with the same symptoms as the more common cervix cancer.
✅We help doctors with a #NETInfo factsheet on gynecological NENs – available in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Neuroendocrine neoplasms (NENs) are often disguised behind common symptoms and can mislead clinicians, which delays diagnosis.
✅We support HCPs to be NEN-aware and make a timely diagnosis with #NETInfo in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Knowledge is power.
The multilingual #NETInfo factsheet on #RadioligandTherapy helps you understand the treatment and feel ready for it.
Available in 15 languages.
✅Download in your language: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
November is #GastricCancerAwarenessMonth.
👉60% of NETs are gastro-intestinal or pancreatic NETs (GEP NET).
👉Approx. 50% of GEP NET patients are misdiagnosed with IBS or gastritis. (SCAN2019)
✅Get to know NETs with #NETInfo in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs
It is #WorldPancreaticCancerDay.
👍Let’s talk about NET of the pancreas. It is a different disease to pancreatic cancer and has a very different treatment pathway and outcome.
✅Help the doctors around you be aware with #NETInfo in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Facing radioligand therapy? You’re not alone.
👉This #NETInfo factsheet on #RadioligandTherapy is designed for neuroendocrine tumor patients to guide you step by step through your treatment journey.
🌍Available in 15 languages.
✅Download now: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Starting radioligand therapy can feel overwhelming.
📌The #RadioligandTherapy #NETInfo factsheet answers your questions and helps you get prepared — in your own language.
🌍Available in 15 languages.
✅Download in your language: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
October is #BreastCancerAwarenessMonth!
Primary neuroendocrine cancers of the breast (NECB) are rare, with an incidence of less than 5% of all breast cancers.
📌We help HCPs to detect breast NETs with #NETInfo in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Knowledge is power.
INCA’s new #NETInfo multilingual factsheet helps you understand radioligand therapy and feel ready for treatment.
Available in 15 languages.
👉 Download here: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
September is #OvarianCancerAwarenessMonth.
📌#NeuroendocrineNeoplasms of the ovaries are uncommon cancers.
✅We help clinicians to be able to make an early correct diagnosis with a #NETInfo factsheet on ovarian NENs – available in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
📢September is #ProstateCancerAwarenessMonth! Prostate NET is less than 2% of all prostate cancers. Symptoms may be similar to having an enlarged prostate or a bladder infection.
📌Consider NETs with #NETInfo in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Are you preparing for radioligand therapy?
INCA’s #NETInfo factsheet on #RadioligandTherapy helps you prepare with confidence knowing what to expect in your everyday life.
• Available in 15 languages.
Download now incalliance.org/net-info-pac...
#LetsTalkAboutNETs
📢NEW: Free NET information in Greek!
The #NETInfo library is now in 12 languages, including Greek language.
✅Download here: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Are you scheduled for radioligand therapy? You do not have to be stressed.
✅Download the #NETInfo factsheet on #RadioligandTherapy to be prepared and stress-free.
🌍Available in 15 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Όλα όσα χρειάζεται να γνωρίζετε για τα NETs.
📌The #NETInfo library is now in 12 languages, including Greek language.
✅Download here: incalliance.org/net-info-pac... #LetsTalkAboutNETs
To confirm #MedullaryThyroidCancer diagnosis, a baseline calcitonin blood test is needed. Calcitonin levels are usually raised when MTC is present.
✅We empower HCPs to detect MTC early with #NETInfo factsheets in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
In most cases of #MedullaryThyroidCancer (MTC), patients may notice a lump in the neck which was not there before. Sometimes MTC may cause diarrhea.
📌We help HCPs to detect MTC early – find #NETInfo in 12 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
Facing radioligand therapy? You’re not alone.
The new #NETInfo factsheet on #RadioligandTHerapy is designed to guide neuroendocrine tumor patients step by step through their treatment journey.
🌍Available in 15 languages.
Download now incalliance.org/net-info-pac...
#LetsTalkAboutNETs
📢INCA is delighted to launch 26 #NETInfo factsheets in a new language – Greek. The #NETInfo library is now in 12 languages: English, Arabic, Chinese, French, German, Greek, Hindi, Italian, Japanese, Portuguese, Russian and Spanish.
✅Download here: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
#MedullaryThyroidCancer (MTC) is a rare form of cancer of the thyroid gland. 25% of cases of MTC occur as part of #MultipleEndocrineNeoplasia Type 2 (MEN2).
✅We help HCPs to detect MTC early – find #NETInfo in 11 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs
📢New to radioligand therapy? Prepare with confidence with the new #NETInfo factsheet from INCA in your language: incalliance.org/net-info-pac...
📌This medically-vetted factsheet on #RadioligandTherapy answers your questions and helps you get prepared.
#LetsTalkAboutNETs
Starting radioligand therapy can feel overwhelming for neuroendocrine cancer patients.
📢INCA launched a NEW #NETInfo factsheet on #RadioligandTherapy designed to support NEN patients.
✅Available in 15 languages to download from #NETInfo Pack: incalliance.org/net-info-pac...
#LetsTalkAboutNETs
